Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 06118 AUSTAR > Detailed Quotes

06118 AUSTAR

Watchlist
2.200
+0.070+3.29%
Closed  12/07 16:08 CCT
High
2.290
Open
2.130
Turnover
2.00M
Low
2.130
Pre Close
2.130
Volume
884.00K
Market Cap
1.13B
P/E(TTM)
8.63
52wk High
16.220
Shares
512.58M
P/E(Static)
3.32
52wk Low
1.270
Float Cap
1.13B
Bid/Ask %
-30.71%
Historical High
30.900
Shs Float
512.58M
Volume Ratio
1.57
Historical Low
0.670
Dividend TTM
--
Div Yield TTM
--
P/B
1.14
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.17%
Amplitude
7.51%
Avg Price
2.256
Lot Size
1000
Float Cap
1.13B
Bid/Ask %
-30.71%
Historical High
30.900
Shs Float
512.58M
Volume Ratio
1.57
Historical Low
0.670
Dividend TTM
--
P/B
1.14
Dividend LFY
--
Turnover Ratio
0.17%
Amplitude
7.51%
Avg Price
2.256
Lot Size
1000
Price Forecast

News

Comment

Sign in to post a comment

No comment yet

Company Overview More
Aoxing Life Technology Co., Ltd. is a leading supplier of engineering solutions for high-end and integrated services and products in China, for well-known pharmaceutical companies and research institutions in China, and to provide these products and services to customers in emerging countries. On November 7, 2014, the company was successfully listed on the main board of the Stock Exchange of Hong Kong Limited (stock code: 6118). Aoxing Group was founded in 1991 and is headquartered in Beijing, China. Aoxing Group provides high-end integrated engineering solutions for customers to set up production facilities and build a clean environment, both of which are crucial to pharmaceutical production. Aoxing's solutions cover fluid and bioprocess systems, clean room and automation control and monitoring systems, powder solid systems and GMP compliance services to assist customers at critical stages of the pharmaceutical life cycle (from research, development, pilot plant, commercial production to product launch). We are also engaged in the manufacture, sales and distribution of all kinds of high-end pharmaceutical equipment and life technology consumables with the joint venture company. The value-added integration engineering solution of Aoxing Group is tailor-made for customers to create some of their production facilities. Aoxing Group assists customers in system construction and the use of hardware and software engineering and technology, including advice on system design, equipment selection, production process, production technology application and verification documentation. Our solutions include the provision of equipment, parts and advice on applied technologies that can improve the efficiency and effectiveness of our customers' production processes. Through the joint venture arrangement with STERIS and PALL, the well-known companies in the life science industry, Aoxing Group is able to integrate these products into integrated engineering solutions based on the complementary relationship with the partners of the joint venture company by making use of the pharmaceutical equipment developed and / or produced by the partners of the joint venture company and the life technology consumables developed and / or produced by the partners of the joint venture company. Provide customers with a variety of high-quality products in the product portfolio.
CEO: Guoqiang He
Market: Hong Kong motherboard
Listing Date: 11/07/2014
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist